Obesity
9 drugs4,513 FAERS reportsMedDRA PT
GET
/api/v1/reaction/obesityReference statistics only. FAERS reports are voluntarily submitted and are not incidence rates, safety signals, or causal evidence. The drugs below are ranked by how often this reaction appears on FAERS reports for each drug — high share does not mean the drug caused the reaction, and absence from this list does not mean the reaction never occurred. This is not a symptom checker.
DefinitionNLM MeSH D009765
A status with BODY WEIGHT that is grossly above the recommended standards, usually due to accumulation of excess FATS in the body. The standards may vary with age, sex, genetic or cultural background. In the BODY MASS INDEX, a BMI greater than 30.0 kg/m2 is considered obese, and a BMI greater than 40.0 kg/m2 is considered morbidly obese (MORBID OBESITY).
Drugs reporting Obesity (9)
Share = reports listing this reaction ÷ total matched reports for the drug. — means the upstream totals query failed at ingest and the denominator is unknown.
- 1Edetate3073%
- 2Edetate Calcium3073%
- 3Trifluoperazine3831%
- 4Carbachol1812%
- 5Iodoquinol25.3%
- 6Thiothixene104.6%
- 7Perphenazine944.5%
- 8Ziprasidone5852.9%
- 9Risperidone3,7062.8%
Related reactions
Other reactions most often co-reported on the same drug set. Ranked by Jaccard similarity over drug-id sets — pure data-derived co-occurrence, not a clinical relationship.
- Airway Remodelling2 shared · 0.22
- Atopy2 shared · 0.22
- Blood Immunoglobulin E Increased2 shared · 0.22
- Central Nervous System Mass2 shared · 0.22
- Eosinophil Count Decreased2 shared · 0.22
- Eosinophil Count Increased2 shared · 0.22
- Eosinophilic Granulomatosis With Polyangiitis2 shared · 0.22
- Microangiopathy2 shared · 0.22
- Nodule2 shared · 0.22
- Antipsychotic Drug Level Below Therapeutic2 shared · 0.20
Literature
Recent PubMed references pinned to Obesity as a MeSH major topic. About the reaction term itself — not about any specific drug.
- Targeting Gut Microbiota by DPP-4 Inhibitors in Obesity: Mechanistic Insights and Therapeutic Implications.Current nutrition reports · 2026 · Alanazi M, Al-Kuraishy HM, Mohamed AA, et al.PMID 42207404DOI 10.1007/s13668-026-00773-1
- Baseline body mass index and early functional recovery after first recorded advanced therapy in rheumatoid arthritis: a real-world cohort study.Rheumatology international · 2026 · Tatar OD, Kılıç L, Kalyoncu U, et al.PMID 42207304DOI 10.1007/s00296-026-06158-5
- THE IMPACT OF OBESITY ON THE CLINICAL COURSE OF INFLAMMATORY BOWEL DISEASE.Arquivos de gastroenterologia · 2026 · Borsato ROR, Chebli JMF, Ribeiro TCDR, et al.PMID 42207082DOI 10.1590/S0004-2803.24612025-093
- After the Prescription: The Clinical Support Gap in Telehealth-Based GLP-1 Care.Journal of medical Internet research · 2026 · Zucker APMID 42206886DOI 10.2196/101874
- Long-Term Effectiveness of a School- and Community-Based Intervention for the Prevention of Childhood Obesity in High-Risk Families Across Europe: The Feel4Diabetes Study.Pediatric obesity · 2026 · Argyropoulou M, Anastasiou CA, Karaglani E, et al.PMID 42204799DOI 10.1111/ijpo.70120
- Sex-specific associations between regular exercise habits and serum myokine levels in adults with obesity.Physiological reports · 2026 · Kurose S, Onishi K, Miyauchi T, et al.PMID 42204771DOI 10.14814/phy2.70930
Note. FAERS reports are voluntarily submitted and are NOT incidence rates, signals, or causal evidence. Counts reflect reporting volume, not how often a reaction occurs. Reference statistics only.